The Role of Brain-Immune Interactions in Immunotoxicology

References

• Munson A. E., McCay J. A., Cao W. Approaches to immunotoxicologic studies with emphasis on chemical-induced immunomodulation. Ann. Allergy 1991; 66(6)505
   PubMedGoogle Scholar
• Luster M. I., Munson A. E., Thomas P., Holsapple M. P., Fenters J. D., White K. L., Lauer L. D., Germolec D. R., Rosenthal G. J., Dean J. H. Development of a testing battery to assess chemical induced immunotoxicity: national toxicology program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 1988; 10: 2
   PubMedGoogle Scholar
• Sanders V. M., Fuchs B. A., Pruett S. B., Kerkvliet N. I., Kaminski N. E. Symposium on indirect mechanisms of immune modulation. Fundam. Appl. Toxicol. 1991; 17: 641
   PubMedGoogle Scholar
• Smith K. A. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169
   PubMed Web of Science ®Google Scholar
• Bateman A., Singh A., Kral T., Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocrine Rev. 1989; 10(1)92
   PubMed Web of Science ®Google Scholar
• Shoham S., Davenne D., Cady A. B., Dinarello C. A., Krueger J. M. Recombinant tumor necrosis factor and interleukin-1 enhance slow-wave sleep. Am. J. Physiol. 1987; 253: R142
   PubMedGoogle Scholar
• Wiedermann C. J. Interleukin-1 interaction with neuroregulatory systems: selective enhancement by recombinant human and mouse interleukin-1 ofin vitro opioid peptide receptor binding in rat brain. J. Neurosci. Res. 1989; 22: 172
   PubMed Web of Science ®Google Scholar
• Fagarasan M. O., Arora P. K., Axelrod J. Interleukin-1 potentiation of b-endorphin secretion and the dynamics of interleukin-1 internalization in pituitary cells. Prog. Neuropsychpharmacol. Biol. Psychiat. 1991; 15: 551
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Ballieux R. E., Heijnen C. J. The role of interleukin-1 in the CRH- and AVP-in duced secretion of ir-β-endorphin by human peripheral blood mononuclear cells. J. Immunol. 1989; 142: 2338
   PubMed Web of Science ®Google Scholar
• Newton R. C., Uhl J., Covington M., Back O. The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res. 1988; 7: 207
   PubMedGoogle Scholar
• Besedovsky H., Del Rey A., Sorkin E., Dinarello C. A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652
   PubMed Web of Science ®Google Scholar
• Gwosdow A. R., Kumar M. S. A., Bode H. H. Interleukin 1 stimulation of the hypothalamic-pitu-itary-adrenal axis. Am. J. Physiol. 1990; 258: E65
   PubMed Web of Science ®Google Scholar
• Woloski B. M. R.N. J., Smith E. ML, Meyer W. J., Fuller G. M., Blalock J. E. Cortico tropin-releasing activity of monokines. Science 1985; 230: 1035
   PubMed Web of Science ®Google Scholar
• Bernton E. W., Beach J. E., Holaday J. W., Smallridge R. C., Fein H. G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987; 238: 519
   PubMed Web of Science ®Google Scholar
• Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522
   PubMed Web of Science ®Google Scholar
• Berkenbosch F., van Oers J., Del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524
   PubMed Web of Science ®Google Scholar
• Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL 1 and TNF). FASEB J. 1990; 4: 2860
   PubMed Web of Science ®Google Scholar
• Lyson K., McCann S. M. The effect of Interleukin-6 on pituitary hormone releasein vivo andin vitro. Neuroendocrinology 1991; 54: 262
   PubMed Web of Science ®Google Scholar
• Spangelo B. L., Judd A. M., Isakson P. C., MacLeod R. M. Interleukin-6 stimulates anterior pituitary hormone releasein vitro. Endocrinology 1989; 125: 575
   PubMed Web of Science ®Google Scholar
• Spangelo B. L., MacLeod R. M., Isakson P. C. Production of interleukin-6 by anterior pituitary cellsin vitro. Endocrinology 1990; 126: 582
   PubMed Web of Science ®Google Scholar
• Spangelo B. L., Isakson P. C., MacLeod R. M. Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′.5′-monophosphate and vasoactive intestinal peptide. Endocrinology 1990; 127: 403
   PubMed Web of Science ®Google Scholar
• Vankelecom H., Carmeliet P., Van Damme J., Billiau A., Denef C. Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 1989; 49: 102
   PubMed Web of Science ®Google Scholar
• Carmeliet P., Vankelecom H., Van Damme J., Billiau A., Denef C. Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology 1991; 53: 29
   PubMed Web of Science ®Google Scholar
• Troisi R. J. P., Mougey E. H., Jackson W. E., Neta R. Interleukin-1 and interleukin-6 act synergis-tically to stimulate the release of adrenocorticotropic hormonein vivo. Lymphokine Cytokine Res. 1991; 10: 141
   PubMedGoogle Scholar
• Hooghe-Peters E., Velkeniers B., Vanhaelst L., Hooghe R. Inter!eukin-1, interleukin-6: messengers in the neuroendocrine immune systemi?. Path. Res. Practice 1991; 187: 622
   PubMed Web of Science ®Google Scholar
• Rivier C., Vale W., Brown M. In the rat, interleukin-1 α and -β stimulate adrenocorticotropin and catecholamine release. Endocrinology 1989; 125: 3096
   PubMed Web of Science ®Google Scholar
• Dunn A. J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 1988; 43: 429
   PubMed Web of Science ®Google Scholar
• Banks W. A., Ortiz L., Plotkin S. R., Kastin A. J. Human interleukin (IL) lα, murine IL-lα and murine IL-l β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 1991; 259(3)988
   PubMed Web of Science ®Google Scholar
• Takao T., Tracey D. E., Mitchell W. M., De Souza E. B. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 1990; 127: 3070
   PubMed Web of Science ®Google Scholar
• Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. NeuroScience 1991; 43: 21
   PubMed Web of Science ®Google Scholar
• Wakabayashi G., Gelfand J. A., Burke J. F., Thompson R. C., Dinarello C. A. A specific receptor antagonist for interleukin 1 preventsEscherichia coli-induced shock in rabbits. FASEB J. 1991; 5: 338
   PubMed Web of Science ®Google Scholar
• Morrissey P. J., Charrier K., Alpert A., Bressler L. in vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone. J. Immunol. 1988; 141(5)1456
   PubMed Web of Science ®Google Scholar
• Weiss J. M., Sundar S. K., Becker K. J., Cierpial M. A. Behavioral and neural influences on cellular immune responses: effects of stress and interleukin-1. J. Clin. Psychiatry 1989; 50: 43
   PubMed Web of Science ®Google Scholar
• Sundar S. K., Becker K. J., Cierpial M. A., Carpenter M. D., Rankin L. A., Fleener S. L., Ritchie J. C., Simson P. E. and Weiss, J. ML, Intracerebroventricular infusion of interleukin-1 rapidly decreases peripheral cellular immune responses. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 6398
   PubMed Web of Science ®Google Scholar
• Sundar S. K., Cierpial M. A., Kilts C., Ritchie J. C., Weiss J. M. Brain IL-1-induced immuno suppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 1990; 10(11)3701
   PubMed Web of Science ®Google Scholar
• Brown R., Li Z., Vriend C., Nirula R., Janz L., Falk J., Nance D. M., Dyck D. G., Greenburg A. H. Suppression of splenic macrophage interleukin 1 secretion following intracerebroventricular injection of interleukin-1β: evidence for pituitary-adrenal and sympathetic control. Cell. Immunol. 1991; 132: 84
   PubMed Web of Science ®Google Scholar
• Akiyoshi M., Shimizu Y., Saito M. Interleukin 1 increases norepinephrine turnover in the spleen and lung in rats. Biochem. Biophys. Res. Commun. 1990; 173: 1266
   PubMed Web of Science ®Google Scholar
• Fisher L. A., Jessen G., Brown M. R. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Reg. Peptides 1983; 5: 153
   PubMedGoogle Scholar
• Fisher L. A., Brown M. R. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function. Brain Res. 1984; 296: 41
   PubMed Web of Science ®Google Scholar
• Brown M. R., Fisher L. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed. Proc. 1985; 44: 243
   PubMedGoogle Scholar
• Fisher L. A. Corticotropin-releasing factor: endocrine and autonomic integration of responses to stress. Trends Pharmacol. Sci. 1989; 10: 189
   PubMed Web of Science ®Google Scholar
• Nikolarakis K., Pfeiffer A., Stalla G. K., Herz A. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats. Brain Res. 1987; 421: 373
   PubMed Web of Science ®Google Scholar
• Nikolarakis K. E., Pfeiffer A., Stalla G. K., Herz A. Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res. 1989; 498: 385
   PubMed Web of Science ®Google Scholar
• Owens M. J., Vargas M. A., Knight D., Nemeroff C. B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. J. Pharmacol. Exp. Ther. 1991; 258(1)349
   PubMed Web of Science ®Google Scholar
• Udelsman R., Harwood J. P., Millan M. A., Chrousos G. P., Goldstein D. S., Zimlichman R., Catt K. J., Aguilera G. Functional cortico tropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 1986; 319: 147
   PubMed Web of Science ®Google Scholar
• Irwin M. R., Vale W., Britton K. T. Central corticotropin-releasing factor suppresses natural killer cytotoxicity. Brain Behav. Immun. 1987; 1: 81
   PubMedGoogle Scholar
• Irwin M., Hauger R. L., Brown M., Britton K. T. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am. J. Physiol. 1988; 255: R744
   Google Scholar
• Irwin M., Hauger R. L., Jones L., Provencio M., Britton K. T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 1990; 255: 101
   PubMed Web of Science ®Google Scholar
• Irwin M., Jones L., Britton K., Hauger R. L. Central corticotropin releasing factor reduces natural cytotoxicity. Time course of action. Neuropsycho pharmacology 1989; 2: 281
   PubMed Web of Science ®Google Scholar
• Irwin M., Vale W., Rivier C. Central corticotropin-releasing factor mediates the suppres sive effect of stress on natural killer cytotoxicity. Endocrinology 1990; 126: 2837
   PubMed Web of Science ®Google Scholar
• Jain R., Zwickler D., Hollander C. S., Brand H., Saperstein A., Hutchinson B., Brown C., Audhya T. Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 1991; 128(3)1329
   PubMed Web of Science ®Google Scholar
• Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Resonberg M., Cohen I. R. T-lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Eur. J. Immunol. 1983; 13: 418
   PubMed Web of Science ®Google Scholar
• Booss J., Suard I., Collins P. V., Jacque C. Disappearance of xenogenic astrocytes transplanted into newborn mice is associated with a T-cell response. Brain Res. 1991; 549: 19
   PubMed Web of Science ®Google Scholar
• Frohman E. M., Bharathi V., van den Noort S., Gupta S. Norepinephrine inhibits gamma-inter-feron-induced MHC class II (la) antigen expression on cultured brain astrocytes. J. Neuroimmunol. 1988; 17: 89
   PubMed Web of Science ®Google Scholar
• Aschner M., Kimelberg H. K. The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. Neurotoxicology 1991; 12: 505
   PubMed Web of Science ®Google Scholar
• Fontana A., Grob P. J. Astrocyte-derived Interleukin-1-like factor. Lymphokine Res. 1984; 1: 11
   Google Scholar
• Giulian D., Baker T. J., Shih L.-C. N., Lachman L. B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 1986; 164: 594
   PubMed Web of Science ®Google Scholar
• Bergsteinsdottir K., Kingston A., Mirsky R., Jessen K. R. Rat Schwann cells produce interleukin-1. J. Neuroimmunol. 1991; 34: 15
   PubMed Web of Science ®Google Scholar
• Breder C. D., Dinarello C. A., Saper C. B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321
   PubMed Web of Science ®Google Scholar
• Hirsch M.-R., Wietzerbin J., Pierres M., Goridis C. Expression of la antigens by cultured astrocytes treated with gamma-interferon. Neurosci. Lett. 1983; 41: 199
   PubMed Web of Science ®Google Scholar
• Satoh J., Kim S. U., Kastrukoff L. F., Takei F. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligoden drocytes and astrocytes. J. Neurosci. Res. 1991; 29: 1
   PubMed Web of Science ®Google Scholar
• Coutinho G. C., Durieu-Trautmann O., Strosberg A. D., Couraud P. O. Catecholamines stimulate the IFN-γ-induced class II MHC expression on bovine brain capillary endothelial cells. J. Immunol. 1991; 147: 2525
   PubMed Web of Science ®Google Scholar
• Male D. K., Pryce G., Hughes C. C. W. Antigen presentation in the brain: MHC induction on brain endothelium and astrocytes compared. Immunology 1987; 60: 453
   PubMed Web of Science ®Google Scholar
• Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984; 307: 273
   PubMed Web of Science ®Google Scholar
• Girgrah N., Ackerley C. A., Moscarello M. A. Localization of CD44 (P80) on the external surface of a human astrocytoma cell. Mol. Neurosci. 1991; 2: 441
   Google Scholar
• Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma treated microglial cells. Eur. J. Immunol. 1987; 17: 1271
   PubMed Web of Science ®Google Scholar
• Janovic B. D., Spector N. H. Effects on the immune system of lesioning and stimulation of the nervous system: neuroimmunomodulation. En kephalins and Endorphins. Stress and the Immune System, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 189
   Google Scholar
• Felten D. L., Cohen N., Ader R., Felten S. Y., Carlson S. L., Foszman T. L. Central neural circuits involved in neural-immune interactions. Psychoneuroimmunology. Academic Press, New York 1991; 3
   Google Scholar
• Cross R. J., Brooks W. H., Roszman T. L., Markesbery W. R. Hypothalamie-immune interactions. Effect of hypophysectomy on neuroimmunomodulation. J. Neurol. Sci. 1982; 53: 557
   PubMed Web of Science ®Google Scholar
• Barneoud P., Neveu P. J., Vitiello S., Le Moal M. Lymphocyte homing after left or right brain neo cortex ablation. Immunol. Lett. 1990; 24: 31
   PubMed Web of Science ®Google Scholar
• Jankovic B. D., Jovanova-Nesic K., Markovic B. M. Neuroimmunomodulation: potentiation of delayed hypersensitivity and antibody production by chronic electrical stimulation of the rat brain. Int. J. Neurosci. 1988; 39: 153
   PubMed Web of Science ®Google Scholar
• Smith E. M., Morrill A. C., Meyer W. J., III, Blalock J. E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986; 321: 881
   PubMed Web of Science ®Google Scholar
• Heijnen C. J., Kavelaars A., Ballieux R. E. Corticotropin-releasing hormone and proopiomelano cortin-derived peptides in the modulation of immune function. Psychoneuroimmunology. Academic Press, New York 1991; 429
   Google Scholar
• Parillo J. E., Fauci A. S. Mechanisms of glu cocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 1979; 19: 179
   PubMed Web of Science ®Google Scholar
• Compton M. M., Caron L. M., Cidlowski J. A. Glucocorticoid action on the immune system. Steroid Biochem. 1987; 27(1–3)201
   PubMedGoogle Scholar
• Audhya T., Jain R., Hollander C. S. Receptor mediated immunomodulation by corticotropin-releasing factor. Cell. Immunol. 1991; 134: 77
   PubMed Web of Science ®Google Scholar
• Singh V. K. Stimulatory effect of corticotropin-releasing factor neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J. Neuroimmunol. 1989; 23: 257
   PubMed Web of Science ®Google Scholar
• Singh V. K., Leu S-J. C. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosc. Lett. 1990; 120: 151
   PubMed Web of Science ®Google Scholar
• McGillis J. P., Park A., Rubin-FIetter P., Turck C., Dallman M. F., Payan D. G. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor. J. Neurosci. Res. 1989; 23: 346
   PubMed Web of Science ®Google Scholar
• Carr D. J. J., DeCosta B. R., Jacobson A. E., Rice K. C., Blalock J. E. Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. J. Neuroimmunol. 1990; 28: 53
   PubMed Web of Science ®Google Scholar
• Leu S-J. C., Singh V. K. Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone. J. Neuroimmunol. 1991; 33: 253
   PubMed Web of Science ®Google Scholar
• Carr D. J. J. The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 1991; 198: 710
   PubMed Web of Science ®Google Scholar
• Carr D. J. J., Blalock J. E. Neuropeptide hormones and receptors common to the immune and neuroendocrine systems: bidirectional pathway of intersystem communication. Psychoneuro immunology. Academic Press, New York 1991; 573
   Google Scholar
• Heijnen C. J., Kavelaars A., Ballieux R. E. β-Endorphin: cytokine and neuropeptide. Immunol. Rev. 1991; 119: 41
   PubMed Web of Science ®Google Scholar
• Oilman S. C., Schwartz J. M., Milner R. J., Bloom F. E., Feldman J. D. β-Endorphin enhances lymphocyte proliferative responses. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 4226
   PubMed Web of Science ®Google Scholar
• Gilmore W., Weiner L. P. The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation. Immunopharmacology 1989; 17: 19
   PubMedGoogle Scholar
• McCain H. W., Lamster I. B., Bozzone J. M., Grbic J. T. β-Endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci. 1982; 31: 1619
   PubMed Web of Science ®Google Scholar
• Mathews P. M., Froelich C. J., Sibbitt W. L., Bankhurst A. D. Enhancement of natural cytotoxic-ity by β-endorphin. J. Immunol. 1983; 130: 1658
   PubMed Web of Science ®Google Scholar
• Chiappelli F., Yamashita N., Faisel M., Kemeny M., Bullington R., Nguyen L., Clement L. T., Fahey J. L. Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmacol. 1991; 13: 291
   PubMed Web of Science ®Google Scholar
• Millar D. B., Hough C. J., Mazorow D. L., Gootenberg J. E. β-Endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependent. Brain Behav. Immun. 1990; 4: 232
   PubMed Web of Science ®Google Scholar
• Mazzanica N., Finzi A. F., Foppa S., Vignati G., Villa M. L. Association between circadian rhythms of endogenous hypothalamic opioid peptides and of natural killer cell activity. Int. J. Immunopharmacol. 1991; 13: 317
   PubMed Web of Science ®Google Scholar
• Chakir J., Rouabhia M., Deschaux P. in vitro effect of methionine-enkephalin and thymosin on murine expression of Thy 1.2 antigen. Immunopharmacology 1989; 17: 31
   PubMedGoogle Scholar
• Faith R. E., Liang H. J., Plotnikoff N. P., Murgo A. J., Nimeh N. F. Neuroimmunomodulation with enkephalins:in vitro enhancement of natural killer cell activity in peripheral blood lymphocytes from cancer patients. Nat. Immun. Cell Growth Regul. 1987; 6: 88
   PubMedGoogle Scholar
• Janovic B. D., Veljic J., Pesic G., Marie D. Enkephalinase-inhibitors modulate immune responses. Int. J. Neurosci. 1991; 59: 45
   PubMed Web of Science ®Google Scholar
• Kuis W., Villiger P. M., Leser H.-G., Lotz M. Differential processing of proenkephalin-A by human peripheral blood monocytes and T lymphocytes. J. Clin. Invest. 1991; 88: 817
   PubMed Web of Science ®Google Scholar
• Behar O. Z., Ovadia H., Polakiewicz R. D., Abramsky O., Rosen H. Regulation of proenkephalin A messenger ribonucleic acid levels in normal B lymphocytes: specific inhibition by glucocorticoid hormones and superinduction by cyclohex imide. Endocrinology 1991; 129: 649
   PubMed Web of Science ®Google Scholar
• Zbrog Z., Luciak M., Tchorzewski H., Pokoca L. Modification of some lymphocyte functionsin vitro by opioid receptor agonists and antagonists in chronic uremic patients and healthy subjects. Int. J. Immunopharmacol. 1991; 43: 475
   Google Scholar
• Maes M., Bosnians E., Suy E., Minner B., Raus J. A further exploration of the relationships between immune parameters and the HPA-axis in depressed patients. Psych. Med. 1991; 21: 313
   Google Scholar
• Barni S., Lissoni P., Crispino S., Cattaneo G., Rovelli F., Fumagalli G., Tancini G. Neuroimmunomodulation in cancer patients: correlations between melatonin and β-endorphin blood levels and T helper/suppressor ratio. Int. J. Biol. Markers 1988; 3: 82
   PubMedGoogle Scholar
• Sanders V. M., Munson A. E. Norepinephrine and the antibody response. Pharmacol. Rev. 1985; 37β: 229
   Google Scholar
• Livnat S., Felten S. Y., Carlson S. L., Bellinger D. L., Felten D. L. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J. Neuroimmunol. 1985; 10: 5
   PubMed Web of Science ®Google Scholar
• Felten D. L., Felten S. Y., Bellinger D. L., Carlson S. L., Ackerman K. D., Madden K. S., Olschowki J. A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 1987; 100: 225
   PubMed Web of Science ®Google Scholar
• Roszman T. L., Carlson S. L. Neurotransmit-ters and molecular signaling in the immune response. Psychoneuroimmunology. Academic Press, New York 1991; 311
   Google Scholar
• Madden K. S., Livnat S. Catecholamine action and immunologic reactivity. Psychoneuroimmunology. Academic Press, New York 1991; 283
   Google Scholar
• Felten D. L., Ackerman K. D., Wiegand S. J., Felten S. Y. Noradrenergic sympathetic innervation of the spleen. I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J. Neurosci. Res. 1987; 18: 28
   PubMed Web of Science ®Google Scholar
• Krammer G. M. The adenylate cyclase-cAMP-pro tein kinase A pathway and regulation of the immune response. Immunol. Today 1988; 9(7/8)222
   PubMedGoogle Scholar
• Galindo B., Imaeda T. Electron microscope study of the white pulp of the mouse spleen. Anat. Rec. 1962; 143: 399
   PubMedGoogle Scholar
• Reilly F. D. Innervation and vascular pharma codynamics of the mammalian spleen. Experentia 1985; 41: 187
   PubMedGoogle Scholar
• Reilly F. D., McCuskey P. A., Meineke H. A. Studies of the hematopoietic microenvironment. VIII. Adrenergic and cholinergic innervation of the murine spleen. Anat. Rec. 1976; 185: 109
   PubMedGoogle Scholar
• Reilly F. D., McCuskey P. A., Miller M. L., McCuskey R. S., Meineke H. A. Innervation of the periarteriolar lymphatic sheath of the spleen. Ti Cell 1979; 11: 121
   PubMed Web of Science ®Google Scholar
• Williams J. M., Peterson R. G., Shea P. A., Schmedtje J. F., Bauer D. C., Felten D. L. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res. Bull. 1981; 6(1)83
   PubMed Web of Science ®Google Scholar
• Felten S. Y., Olschowka J. Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hy droxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 1987; 18: 37
   PubMed Web of Science ®Google Scholar
• Felten S. Y., Felten D. L. Innervation of lym phoid ti. Psychoneuroimmunology. Academic Press, New York 1991; 27
   Google Scholar
• Williams J. M., Felten D. L. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat. Rec. 1981; 199: 531
   PubMedGoogle Scholar
• Felten D. L., Livnat S., Felten S. Y., Carlson S. L., Bellinger D. L., Yeh P. Sympathetic innervation of lymph nodes in mice. Brain Res. Bull. 1984; 13: 693
   PubMed Web of Science ®Google Scholar
• Felten D. L., Felten S. Y., Carlson S. L., Olschowka J. A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid ti. J. Immunol. 1985; 135(2)755s
   Web of Science ®Google Scholar
• Draskoci M., Jankovic B. D. Involution of thymus and suppression of immune responses in rats treated with reserpine. Nature (London) 1964; 202: 408
   PubMed Web of Science ®Google Scholar
• Kasahara K., Tanaka S., Ito T., Hamashima Y. Suppression of the primary immune response by chemical sympathectomy. Res. Comm. Chem. Pathol. Pharmacol. 1977; 16(4)687
   PubMedGoogle Scholar
• Hall N. R., McClure J. E., Hu S., Tare S., Seals C. M., Goldstein A. L. Effects of 6-hydroxy dopamine upon primary and secondary thymus dependent immune responses. Immunopharmacology 1982; 5: 39
   PubMedGoogle Scholar
• Besedovsky H. O., Del Rey A., Sorkin E., Da Prada M., Keller H. H. Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 1979; 48: 346
   PubMed Web of Science ®Google Scholar
• Miles K., Quintans J., Chelmicka-Schorr E., Arnason B. G. W. The sympathetic nervous system modulates antibody response to thymus-independent antigens. J. Neuroimmunol. 1981; 1: 101
   PubMed Web of Science ®Google Scholar
• Miles K., Chelmicka-Schorr E., Atweh S., Otten G., Arnason B. G. W. Sympathetic ablation alters lymphocyte membrane properties. J. Immunol. 1985; 135(2)797s
   Web of Science ®Google Scholar
• Miles K., Atweh S., Otten G., Arnason B. G. W., Chelmicka-Schorr E. b-Adrenergic receptors on splenic lymphocytes from axotomized mice. Int. J. Immunopharmacol. 1984; 6(3)171
   PubMed Web of Science ®Google Scholar
• Fuchs B. A., Campbell K. S., Munson A. E. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte β-adren ergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 1988; 117: 339
   PubMed Web of Science ®Google Scholar
• Chelmicka-Schorr E., Checinski M., Arnason B. G. W. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 1988; 17: 347
   PubMed Web of Science ®Google Scholar
• Del Rey A., Besedovsky H. O., Sorkin E., Da Prada M., Bondiolotti G. P. Sympathetic immunoregulation: difference between high- and low-responder animals. Am. J. Physiol. 1982; 242: R30
   PubMed Web of Science ®Google Scholar
• Besedovsky H. O., Del Rey A. E., Sorkin E. Immune-neuroendocrine interactions. J. Immunol. 1985; 135(2)750s
   Web of Science ®Google Scholar
• Fuchs B. A., Albright J. W., Albright J. F. β-Adrenergic receptor on murine lymphocytes: density varies with cell maturity and lymphocyte subtype and is decreased after antigen administration. Cell. Immunol. 1988; 114: 231
   PubMed Web of Science ®Google Scholar
• Cross R. J., Jackson J. C., Brooks W. H., Sparks D. L., Markesbery W. R., Roszman T. L. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6- hydroxydopamine treatment. Immunology 1986; 57: 145
   PubMed Web of Science ®Google Scholar
• Cross R. J., Brooks W. H., Roszman T. L. Modulation of T-suppressor cell activity by central nervous system catecholamine depletion. J. Neurosci. Res. 1987; 18: 75
   PubMed Web of Science ®Google Scholar
• Ackerman K. D., Madden K. S., Livnat S., Felten S. Y., Felten D. L. Neonatal sympathetic den-ervation alters the development ofin vitro spleen cell proliferation and differentiation. Brain Behav. lmmun. 1991; 5: 235
   PubMed Web of Science ®Google Scholar
• Pochet R., Deiespesse G., Gausset P. W., Collet H. Distribution of beta-adrenergic receptors on human lymphocyte subpopulations. Clin. Exp. Immunol. 1979; 38: 578
   PubMed Web of Science ®Google Scholar
• Johnson D. L., Gordon M. A. Characteristics of adrenergic binding sites associated with murine lymphocytes isolated from spleen. J. Immun opharmacol. 1980; 2: 435
   PubMed Web of Science ®Google Scholar
• Loveland B. E., Jarrott B., McKenzie I. F. C. The detection of β-adrenoceptors on murine lymphocytes. Int. J. Immunopharmacol. 1981; 45
   Google Scholar
• Leiros C. P., Borda E. Characterization of (-)-3H-DHA binding to intact mouse lymphocytes: effect of experimental autoimmune orchitis on β-adrenoceptor expression. Int. J. Immunopharmacol. 1986; 8(4)405
   PubMed Web of Science ®Google Scholar
• Khan M. M., Sansoni P., Silverman E. D., Engleman E. G., Melmon K. L. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biol. Psychiat. 1986; 35: 1137
   Google Scholar
• Van Tits L. J. H., Michel M. C., Grosse-Wilde H., Happel M., Eigler F.-W., Soliman A., Brodde O.-E. Catecholamines increase lymphocyte β2-adr energic receptors via a β2-adrenergic, spleen-dependent process. Am. J. Physiol. 1990; 258: E191
   PubMed Web of Science ®Google Scholar
• Strom T. B., Carpenter C. B. Cyclic Nucle otides in immunosuppression-neuroendocrine pharmacologic manipulation andin vivo immuno-regulation of immunity acting via second messenger systems. Trans. Proc. 1980; 12(2)304
   PubMed Web of Science ®Google Scholar
• Dailey M. O., Schreurs J., Schulman H. Hormone receptor on cloned T lymphocytes: increased responsiveness to histamine, prostaglandins and β-adrenergic agents as a late stage event in T cell activation. J. Immunol. 1988; 140(9)2931
   PubMed Web of Science ®Google Scholar
• Radojcic T., Baird S., Darko D., Smith D., Bulloch K. Changes in b-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 1991; 30: 328
   PubMed Web of Science ®Google Scholar
• Westly H. J., Kelley K. W. Down-regulation of glucocorticoid and β-adrenergic receptors on lectin-stimulated splenocytes. Proc. Soc. Exp. Biol Med. 1987; 185: 211
   PubMed Web of Science ®Google Scholar
• Cremaschi G. A., Fisher P., Boege F. β-Adrenoceptor distribution in murine lymphoid cell lines. Immiinopharmacology 1991; 22: 195
   PubMedGoogle Scholar
• Bohm M., Gengenbach S., Hauck R. W., Sunder-Plassmann L., Erdmann E. Beta-adrenergic receptors and μ-cholinergic receptors in human lung. Findings followingin vivo andin vitro exposure to the β-adrenergic receptor agonist, terbutaline. Chest 1991; 100: 1246
   PubMed Web of Science ®Google Scholar
• Haen E., Hauck R., Emslander H. P., Langen-mayer I., Liebl B., Schopohl J., Remien J., Fruhmann G. Nocturnal asthma. β2-adrenoceptors on peripheral mononuclear leukocytes, cAMP- and cortisol-plasma concentrations. Chest 1991; 100: 1239
   PubMed Web of Science ®Google Scholar
• Kishimoto S., Tomino S., Inomata K., Kotegawa S., Saito T., Kuroki M., Mitsuya H., Hisamitsu S. Age-related changes in the subsets and functions of human T lymphocytes. J. Immunol. 1978; 121: 1773
   PubMed Web of Science ®Google Scholar
• Naliboff B. D., Benton D., Soloman G. F., Morley J. E., Fahey J. L., Bloom E. T., Makinodan T., Gilmore S. L. Immunological changes in young and old adults during brief laboratory stress. Psychosom. Med. 1991; 53: 121
   PubMed Web of Science ®Google Scholar
• Feldman R. D., Limbird L. E., Nadeau J., Robertson D., Wood A. J. Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. N. Engl. J. Med. 1984; 310(13)815
   PubMed Web of Science ®Google Scholar
• Gietzen D. W., Goodman T. A., Weiler P. G., Graf K., Fregeau D. R., Magliozzi J. R., Doran A. R., Maddock R. J. Beta receptor density in human lymphocyte membranes: changes in aging. J. Gerontol. 1991; 46: B130
   Google Scholar
• Felten S. Y., Bellinger D. L., Collier T. J., Coleman P. D., Felten D. L. Decreased sympathetic innervation of spleen in aged Fischer 344 rats. Neurobiol. Aging 1987; 159
   PubMed Web of Science ®Google Scholar
• Cross R. J., Campbell J. L., Markesbery W. R., Roszman T. L. Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice. Mechan. Ageing Dev. 1990; 56: 11
   PubMed Web of Science ®Google Scholar
• Rossolini G., Viticchi C., Basso A., Zaia A., Piantanelli L. Thymus-induced recovery of age related decrease of brain cortex a- and β-adrenoceptors. Int. J. Neurosci. 1991; 59: 143
   PubMed Web of Science ®Google Scholar
• Bovbjerg D. H., Kim Y. T., Schwab R., Schmitt K., DeBlasio T., Weksler M. E. “Cross-wiring” of the immune response in old mice: increased au toantibody response despite reduced antibody response to nominal antigen. Cell. Immunol. 1991; 137: 36
   PubMedGoogle Scholar
• Goya R. G. The immune-neuroendocrine homeo static network and aging. Gerontology 1991; 37: 208
   PubMed Web of Science ®Google Scholar
• Bellinger D. L., Lorton D., Felten S. Y., Felten D. L. Noradrenergic and peptidergic neural immune interactions in aging. Stress and the Aging Brain, G. Nappi. Raven Press, New York 1990; 143
   Google Scholar
• Maes M., Bosmans E., Suy E., Minner B., Raus J. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrener-gic activity, and the ageing process. Br. J. Psychol. 1989; 155: 793
   Google Scholar
• Halper J. P., Brown R. P., Sweeney J. A., Kocsis J. H., Peters A., Mann J. Blunted β-adrener gic responsivity of peripheral blood mononuclear cells in endogenous depression. Arch. Gen. Psychiat. 1988; 45: 241
   PubMed Web of Science ®Google Scholar
• Jeanningros R., Mazzola P., Azorin J. M., Samuelian-Massa C., Tissot R. β-Adreno ceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol. Psychiatr. 1991; 29: 789
   PubMed Web of Science ®Google Scholar
• Stein M., Miller A. H., Trestman R. L. Depression, the immune system, and health and illness. Arch. Gen. Psychiat. 1991; 48: 171
   PubMed Web of Science ®Google Scholar
• Stein M., Miller A. H., Trestman R. L. Depression and the immune system. Psychoneuro immunology. Academic Press, New York 1991; 897
   Google Scholar
• Braun W., Rega M. J. Adenyl cyclase-stimu lating catecholamines as modifiers of antibody formation. Immunol. Commun. 1972; 1: 523
   PubMed Web of Science ®Google Scholar
• Burchiel S. W., Melmon K. L. Augmentation of thein vitro humoral immune response by pharmacologic agents. II. The comparison of the effects of antiproliferative agents with DBcAMP. Immunopharmacology 1979; 1: 151
   PubMedGoogle Scholar
• Sanders V. M., Munson A. E. Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody responsein vitro. J. Pharmacol. Exp. Ther. 1984; 230(1)183
   PubMed Web of Science ®Google Scholar
• Sanders V. M., Munson A. E. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody responsein vitro. J. Pharmacol. Exp. Ther. 1984; 231β: 527
   Google Scholar
• Kouassi E., Li Y. S., Boukhris W., Millet L., Revillard J.-P. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. Immunopharmacology 1988; 16: 125
   PubMedGoogle Scholar
• Melmon K. L., Bourne H. R., Weinstein Y., Shearer G. M., Kram J., Bauminger S. Hemolytic plaque formation by leukocytesin vitro: control by vasoactive amines. J. Clin. Invest. 1974; 53: 13
   PubMed Web of Science ®Google Scholar
• Sanders V. M., Munson A. E. Role of alpha adrenoceptor activation in modulating the murine primary antibody responsein vitro. J. Pharmacol. Exp. Ther. 1985; 232(2)395
   PubMed Web of Science ®Google Scholar
• Sanders V. M., Powell-Oliver F. E. β2-adreno-ceptor stimulation increases the number of antigen specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 1992; 148(6)1822
   PubMed Web of Science ®Google Scholar
• Fuchs B. A., McCall C. O., Munson A. E. Enhancement of the murine primary antibody response by phenylephrinein vitro. Drug Chem. Toxicol. 1991
   PubMed Web of Science ®Google Scholar
• Brosnan C. F., Goldmuntz E. A., Cainmer W., Factor S. M., Bloom B. R., Norton W. T. Prazosin, and α-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 5915
   PubMed Web of Science ®Google Scholar
• Hadden J. W., Hadden E. M., Middleton E. Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell. Immunol. 1970; 1: 583
   PubMedGoogle Scholar
• Coderre T. J., Basbaum A. I., Helms C., Levine J. D. High-dose epinephrine acts at α2-adrenoceptors to suppress experimental arthritis. Brain Res. 1991; 544: 325
   PubMed Web of Science ®Google Scholar
• Rall T. W. Role of adenosine 3′,5′-monophosphate (cyclic AMP) in actions of catecholamines. Pharmacol. Rev. 1972; 24: 399
   PubMed Web of Science ®Google Scholar
• Garcia-Sainz J. A., Hoffman B. B., Li S., Lefkowitz R. J., Fain J. N. Role of alpha 1 adrenoceptors in the turnover of phosphatidylinositol and the alpha 2 adrenoceptors in the regulation of cyclic AMP in hamster adipocytes. Life Sci. 1980; 27: 953
   PubMed Web of Science ®Google Scholar
• Hahn W. C., Rosenstein Y., Burakoff S. J., Bierer B. E. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3′,5′-cyclic monophosphate production in T lymphocytes. J. Immunol. 1991; 147: 14
   PubMed Web of Science ®Google Scholar
• Cambier J. C., Newell M. K., Justement L. B., McGuire J. C., Leach K. L., Chen Z. Z. Ia binding ligands and cAMP stimulate nuclear translo-cation of PKC in B lymphocytes. Nature 1987; 327: 629
   PubMed Web of Science ®Google Scholar
• Feuerstein N., Lindsberg M. L., Tung L., Francis M. L., Mond J. J. Identification of a prominent 85-kDa cAMP-dependent phosphoprotein associated with late Gl phase in mitogen-stimulated B lymphocytes. J. Biol. Chem. 1991; 266: 4746
   PubMed Web of Science ®Google Scholar
• Bishop G. A. Requirements of class II-mediated B cell differentiation for Class II crosslinking and cyclic AMP. J. Immunol. 1991; 147: 1107
   PubMed Web of Science ®Google Scholar
• Pollok K. E., O'Brien V., Marshall L., Olson J. W., Noelle R. J., Snow E. C. The development of competence in resting B cells: the induction of cyclic AMP and ornithine decarboxylase activity after direct contact between B and T helper cells. J. Immunol. 1991; 146: 1633
   PubMed Web of Science ®Google Scholar
• Gilbert K. M., Hoffman M. K. cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells. J. Immunol. 1985; 135(3)2084
   PubMed Web of Science ®Google Scholar
• Vasquez A., Auffredou M. T., Galanaud P., Leca G. Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP. J. Immunol. 1991; 146: 4222
   PubMed Web of Science ®Google Scholar
• Klaus G. G. B., Vondy K., Holman M. Selective effects of cholera toxin on the activation of mouse B cells by different polyclonal activators. Eur. J. Immunol. 1987; 17: 1787
   PubMed Web of Science ®Google Scholar
• Roper R. L., Conrad D. H., Brown D. M., Warner G. L., Phipps R. P. Prostaglandin E2 promotes IL-4-induced IgE and IgGl synthesis. J. Immunol. 1990; 145: 2644
   PubMed Web of Science ®Google Scholar
• Dugas B., Paul-Eugene N., Genot E., Menica-Huerta J. M., Braquet P., Kolb J. P. Effect of bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera toxin. Eur. J. Immunol. 1991; 21: 495
   PubMed Web of Science ®Google Scholar
• Warner G. L., Davies S., Scott D. W. Cholera toxin-sensitive and insensitive signalling via surface Ig. J. Immunol. 1989; 143: 458
   PubMed Web of Science ®Google Scholar
• Francis M. L., Moss J., Fitz T. A., Mond J. J. cAMP-independent effects of cholera toxin on B cell activation. 1. A possible role for cell surface gan-glioside Gml, in B cell activation. J. Immunol. 1990; 145: 3162
   PubMed Web of Science ®Google Scholar
• Anastassiou E. D., Yamada H., Francis M. L., Mond J. J., Tsokos G. C. Effects of cholera toxin on B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-μ antibody-induced cell proliferation. J. Immunol. 1990; 145: 2375
   PubMed Web of Science ®Google Scholar
• Patke C. L., Orson F. M., Shearer W. T. Cyclic AMP-mediated modulation of immunoglobu-lin production in B cells by prostaglandin El. Cell. Immunol. 1991; 137: 36
   PubMed Web of Science ®Google Scholar
• Stein S. H., Phipps R. P. Antigen-specific IgG2a production in response to prostaglandin E2, immune complexes, and IFN-γ. J. Immunol. 1991; 147: 2500
   PubMed Web of Science ®Google Scholar
• Feldman R. D., Hunninghake G. W., McArdle W. β-Adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 1987; 139(10)3355
   PubMed Web of Science ®Google Scholar
• Wacholtz M. C., Minakuchi R., Lipsky P. E. Characterization of the 3′.5′-cyclic adenosine mono-phosphate-mediated regulation of IL2 production by T cells and Jurkat cells. Cell. Immunol. 1991; 135: 285
   PubMed Web of Science ®Google Scholar
• Carlson S. L., Brooks W. H., Roszman T. L. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 1989; 24: 155
   PubMed Web of Science ®Google Scholar
• Johnson K. W., Smith K. A. cAMP Regulation of IL-2 receptor expression. Selective modulation of the p75 subunit. J. Immunol. 1990; 145(4)1144
   PubMed Web of Science ®Google Scholar
• Parker C. W. Role of cyclic nucleotides in regulating lymphocytes. Ann. N.Y. Acad. Sci. 1979; 332: 255
   PubMedGoogle Scholar
• Wang T., Sheppard J., Foker J. Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis. Science 1978; 201(14)155
   PubMedGoogle Scholar
• Yamamoto I., Webb D. R. Antigen stimulated changes in cyclic nucleotide levels in the mouse. Proc. Natl. Acad. Sci. U.S.A. 1975; 72(6)2320
   PubMed Web of Science ®Google Scholar
• Plescia O. J., Yamamoto I., Shimamura T. Cyclic AMP and immune responses: changes in the splenic level of cyclic AMP during the response of mice to antigen. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 888
   PubMed Web of Science ®Google Scholar
• Chaplin D. D., Wedner H. J., Parker C. W. Protein phosphorylation in human peripheral blood lymphocytes. II. Phosphorylation of endogenous plasma membrane and cytoplasmic proteins. Biochem. J. 1979; 182: 537
   PubMed Web of Science ®Google Scholar
• Ortez R. A. Cyclic AMP-dependent content of murine splenic T and B lymphocytes and non-lym-phoid tis. Immunol. Comm. 1982; 11: 227
   PubMed Web of Science ®Google Scholar
• De Blasi A., Lipartiti M., Algeri S., Sacchetti G., Constantini C., Fratelli M., Cotecchia S. Stress induced desensitization of lymphocyte β-adrenoceptors in young and aged rats. Pharmacol. Biochem. Behav. 1986; 24: 991
   PubMed Web of Science ®Google Scholar
• Mormede P., Dantzer R., Michaud B., Kelley K. W., Le Moal M. Influence of stressor predictability and behavioral control on lymphocyte reactivity, antibody responses and neuroendocrine activation in rats. Physiol. Behav. 1988; 43: 577
   PubMed Web of Science ®Google Scholar
• Sheridan J. F., Feng N., Bonneau R. H., Allen C. M., Huneycutt B. S., Glaser R. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J. Neuroimmunol. 1991; 31: 245
   PubMed Web of Science ®Google Scholar